Affiliations: Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands | Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands | Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands | Department of Pathology, Rijnland Hospital, Leiderdorp, The Netherlands
Note: [] Corresponding author: Prof. Dr. H.J. Tanke, Head Department of Molecular Cell Biology, Leiden University Medical Center (Zone S1-P), Postbus 9600, 2300 RC, Leiden, The Netherlands. Tel.: +31 71 526 9201; Fax: +31 71 526 8270; E-mail: [email protected].
Abstract: Background: For stage I–II colon cancer a significant number (5–25%) of patients has recurrent disease within 5 years. There is need to identify these high-risk patients as they might benefit from additional treatment. Stroma-tissue surrounding the cancer cells plays an important role in the tumor behavior. The proportion of intra-tumor stroma was evaluated for the identification of high-risk patients. In addition, protein expression of markers involved in pathways related to stroma production and epithelial-to-mesenchymal transition (EMT) was analyzed: β-catenin, TGF-β-R2 and SMAD4. Methods: In a retrospective study of 135 patients with stage I–II colon cancer, the amount of stroma was estimated on routine haematoxylin–eosin stained histological sections. Sections were also immunohistochemically stained for β-catenin, TGF-β-R2 and SMAD4. Results: Of 135 analyzed patients 34 (25.2%) showed a high proportion of stroma (stroma-high) and 101 (74.8%) a low proportion (stroma-low). Significant differences in overall-survival and disease-free-survival were observed between the two groups, with stroma-high patients showing poor survival (OS p<0.001, HZ 2.73, CI 1.73–4.30; DFS p<0.001, HZ 2.43, CI 1.55–3.82). A high-risk group was identified with stroma-high and SMAD4 loss (OS p=0.008, HZ 7.98, CI 4.12–15.44, DFS p=0.005, HZ 6.57, CI 3.43–12.56); 12 of 14 (85.7%) patients died within 3 years. In a logistic-regression analysis a high proportion of stroma and SMAD4 loss were strongly related (HZ 5.42, CI 2.13–13.82, p<0.001). Conclusions: Conventional haematoxylin–eosin stained tumor slides contain more prognostic information than previously fathomed. This can be unleashed by assessing the tumor–stroma ratio. The combination of analyzing the tumor–stroma ratio and staining for SMAD4 results in an independent parameter for confident prediction of clinical outcome.
